<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04640597</url>
  </required_header>
  <id_info>
    <org_study_id>MIMICS-3D-USA</org_study_id>
    <nct_id>NCT04640597</nct_id>
  </id_info>
  <brief_title>MIMICS-3D-USA Registry Study</brief_title>
  <official_title>A Prospective, Multicentre Observational Study to Evaluate the BioMimics 3D Vascular Stent System in the Treatment of Peripheral Arterial Disease: MIMICS-3D-USA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Veryan Medical Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Veryan Medical Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The MIMICS-3D-USA Study is a prospective, multicentre, observational study&#xD;
      (non-investigational) of the BioMimics 3D Vascular Stent System that evaluates evaluate&#xD;
      safety, effectiveness and device performance within a real-world clinical population of&#xD;
      patients undergoing femoropopliteal intervention for the treatment of peripheral artery&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The MIMICS-3D-USA Study is designed to enable the collection, analysis, reporting and&#xD;
      presentation of data from use of the BioMimics 3D Vascular Stent System purchased by the&#xD;
      hospital / institution or office interventional suite and used in accordance with the IFU&#xD;
      associated with the product's FDA approval. The intent of this post-market observational&#xD;
      study is to increase the understanding of the performance of the BioMimics 3D Vascular Stent&#xD;
      System in a larger population of patients representative of a real-world situation within US&#xD;
      hospitals, institutions and office-based interventional suites or labs.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 18, 2020</start_date>
  <completion_date type="Anticipated">December 18, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 18, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>36 Months</target_duration>
  <primary_outcome>
    <measure>Safety endpoint of number of subjects of freedom from CEC-adjudicated major adverse events (MAE) comprising death, any unplanned major amputation performed on the index limb or clinically driven target lesion revascularization (CDTLR) through 30 days.</measure>
    <time_frame>30 Days</time_frame>
    <description>Freedom from major adverse events expressed as a percentage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary effectiveness endpoint of number of subjects of freedom from CEC Adjudicated clinically driven target lesion revascularization (CDTLR) through 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>Freedom from CDTLR at 12 Months expressed as a percentage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success defined as delivery and deployment of the study stent to achieve a final residual diameter stenosis of ≤30% measured by visual assessment of angiographic imaging at the end of the study procedure on Day 0.</measure>
    <time_frame>Procedural</time_frame>
    <description>Number of participants with final residual stenosis ≤30%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural success defined as technical success with absence of MAE (comprising death,</measure>
    <time_frame>24 hours after index procedure</time_frame>
    <description>Number of participants with acute technical success and absence of MAE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of components of CEC-adjudicated MAE.</measure>
    <time_frame>30 days, 12, 24 and 36 months</time_frame>
    <description>Incidence of individual components of CEC-adjudicated MAE (death, any unplanned major amputation performed on the index limb or CDTLR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall rate and incidence of adverse events</measure>
    <time_frame>36 Months</time_frame>
    <description>Overall rate and incidence of adverse events from Day 0 to completion of study follow-up at month 36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary Stent Patency rate determined by core lab adjudicated, duplex ultrasound at 12 Months</measure>
    <time_frame>12 Months</time_frame>
    <description>Primary Stent Patency expressed as a percentage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of mean Rutherford Clinical Category measured at Baseline, Day 30, Months 12, 24 and 36.</measure>
    <time_frame>Baseline, Day 30, Months 12, 24 and 36.</time_frame>
    <description>Compare RCC at each of the follow-up visit with the Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional outcome: ankle brachial index measurement comparison</measure>
    <time_frame>Baseline, within 30 days after index procedure, then at Month 12.</time_frame>
    <description>Comparison of the ankle brachial index (ABI) measurement at Baseline, within 30 days after index procedure, then at Month 12.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the quality of life (QoL) score at Baseline, within 30 days after index procedure, then at Months 12, 24 and 36</measure>
    <time_frame>Baseline, Day 30, Months 12, 24 and 36.</time_frame>
    <description>Compare the change in QoL score compared to the Baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stent fractures</measure>
    <time_frame>36 Months</time_frame>
    <description>Incidence of reported stent fracture reported by investigational sites through 36 months</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BioMimics 3D Vascular Stent System</intervention_name>
    <description>Patients with BioMimics 3D Vascular Stent System</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who receive treatment with Veryan's BioMimics 3D Vascular Stent System in&#xD;
        accordance with the current approved FDA (PMA # 180003 approval) indication for use as&#xD;
        stated in the Instructions for Use (IFU) will be consecutively enrolled in this study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is age ≥18 and ≤85 years at the date of consent.&#xD;
&#xD;
          -  Patient has provided written informed consent for participation in the study prior to&#xD;
             index procedure.&#xD;
&#xD;
          -  Patient has documented symptomatic peripheral arterial disease scheduled for treatment&#xD;
             with the BioMimics 3D Vascular Stent System in accordance with the IFU.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients whose lesions cannot be crossed with a wire and/or balloon catheter and&#xD;
             cannot be dilated sufficiently to allow passage of the delivery system.&#xD;
&#xD;
          -  Patients with a history of intolerance or adverse reaction to antiplatelet and/or&#xD;
             anticoagulation therapies, bleeding diathesis or severe hypertension.&#xD;
&#xD;
          -  Patients with known hypersensitivity to nickel-titanium.&#xD;
&#xD;
          -  Patient has a comorbidity that in the Investigator's opinion would limit life&#xD;
             expectancy to less than 12 months.&#xD;
&#xD;
          -  Patient is pregnant or breastfeeding.&#xD;
&#xD;
          -  Patient is unable or is unwilling to comply with site standard of care procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nuwani Edirisinghe</last_name>
    <role>Study Director</role>
    <affiliation>Veryan Medical</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>LeRoy Moriuchi</last_name>
    <phone>+1 240 641 1718</phone>
    <email>Leroy.moriuchi@veryanmed.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alabama Clinical Therapeutics, LLC</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jill Andringa</last_name>
      <email>jill.andringa@actstudy.net</email>
    </contact>
    <contact_backup>
      <last_name>Lisa Palmedo</last_name>
      <phone>+1 205 833 2228</phone>
      <email>lisa.palmedo@actstudy.net</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Foster, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacob Towsend, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jason Thompson, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Yoe, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joshua Cockrell, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Trimm, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joshua Turner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Southeast</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35243</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tammy Stover</last_name>
      <phone>205-599-6374</phone>
      <email>tstover@cvapc.com</email>
    </contact>
    <investigator>
      <last_name>Jan Skowronski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pulse Cardiovascular Institute</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Priya Ramaiah</last_name>
      <phone>480-747-1525</phone>
      <email>priya@pulsecardiovascular.com</email>
    </contact>
    <investigator>
      <last_name>Venkatesh Ramaiah</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Solutions Institute</name>
      <address>
        <city>Bradenton</city>
        <state>Florida</state>
        <zip>34208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Coffin</last_name>
      <phone>941-747-8789</phone>
      <email>jamies@cvsifl.com</email>
    </contact>
    <investigator>
      <last_name>Gino Sedillo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Palm Vascular Centers</name>
      <address>
        <city>Miami Beach</city>
        <state>Florida</state>
        <zip>33140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Gimeno</last_name>
      <phone>305-763-8734</phone>
      <email>jennifer@palmvascular.com</email>
    </contact>
    <investigator>
      <last_name>Robert Beasely, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timothy Yates, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Warren Swee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franklin Gracia-Godoy, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coastal Vascular &amp; Interventional, PLLC</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32504</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Stewart</last_name>
      <phone>850-494-1108</phone>
      <email>kelly.stewart@coastalvi.com</email>
    </contact>
    <investigator>
      <last_name>Chris LeCroy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geoffery Risley, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aaron Montgomery, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Kafie, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Bosarge, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shonak Patel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Midwest Cardiovascular Research Foundation</name>
      <address>
        <city>Davenport</city>
        <state>Iowa</state>
        <zip>52801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Christensen</last_name>
      <phone>563-271-6182</phone>
      <email>chistensenl@mcrfmd.com</email>
    </contact>
    <investigator>
      <last_name>Nicolas Shammas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jon Robken, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Coastal Vascular &amp; Interventional, PLLC</name>
      <address>
        <city>Davenport</city>
        <state>Iowa</state>
        <zip>52807</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Jarrett</last_name>
      <phone>563-313-0078</phone>
      <email>lynn.jarrett@vimidwest.com</email>
    </contact>
    <investigator>
      <last_name>Eric Dippel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Pena-Quevedo</last_name>
      <phone>319-353-8736</phone>
      <email>judith-pena-quevedo@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Mel Sharafuddin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maen Aboul Hosn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jun Xu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natalie Weger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CIS Clinical Research Corporation</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Darla Patrick</last_name>
      <phone>985-873-5684</phone>
      <email>Darla.patrick@cardio.com</email>
    </contact>
    <investigator>
      <last_name>Craig Walker, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pradeep Nair, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andres Estrada, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Louisiana Cardiovascular &amp; Limb Salvage Center</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <zip>70503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cindy Landry</last_name>
      <phone>337-257-5246</phone>
      <email>clandry@cv-limbsalvage.com</email>
    </contact>
    <investigator>
      <last_name>David Allie, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raghotham Patlola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brent Rochon, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vascular Care Group</name>
      <address>
        <city>Wellesley</city>
        <state>Massachusetts</state>
        <zip>02482</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Gagne</last_name>
      <phone>203-912-3227</phone>
      <email>epgagne@optonline.net</email>
    </contact>
    <investigator>
      <last_name>Christopher Kwolek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Todd Lancaster, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Hoenig, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Gorin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eddie Arous, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth Mahanor, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NJ Endovascular and Amputation Prevention, LLP</name>
      <address>
        <city>Clifton</city>
        <state>New Jersey</state>
        <zip>07013</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Hlozek</last_name>
      <phone>857-334-0851</phone>
      <email>kristen@lebecc.com</email>
    </contact>
    <investigator>
      <last_name>John Rundback, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kevin Herman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Irving Medical Center/NYPH</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Dalton</last_name>
      <email>Keb2114@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Treena Williams</last_name>
      <phone>212-342-3485</phone>
      <email>taw2112@cumc.columbia.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sahil Parikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ajay Kirtane, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Pucillo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sanjum Sethi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Finn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate Dalton</last_name>
      <phone>347-514-3366</phone>
      <email>keb2114@cumc.columbia.edu</email>
    </contact>
    <investigator>
      <last_name>Sahil Parikh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ajay Kirtane, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anthony Pucillo, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sanjum Sethi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Matthew Finn, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amputation Prevention Center of North Carolina</name>
      <address>
        <city>Cary</city>
        <state>North Carolina</state>
        <zip>27518</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jessica Blalock</last_name>
      <phone>919-452-0449</phone>
      <email>jblalock@apcnc.org</email>
    </contact>
    <contact_backup>
      <last_name>Phalan Bolden</last_name>
      <email>phalan@apcnc.org</email>
    </contact_backup>
    <investigator>
      <last_name>Siddhartha Rao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>US cardiovascular of Greenburg</name>
      <address>
        <city>Jefferson Hills</city>
        <state>Pennsylvania</state>
        <zip>15025</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori DeGore</last_name>
      <phone>412-405-9585</phone>
      <email>lori@uscardiovascular.com</email>
    </contact>
    <investigator>
      <last_name>Gennady Geskin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Mulock, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Michael Brown, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicole Bruno</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Meghan Neil</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ascension Seton Heart Institute</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aimee Shadrach</last_name>
      <phone>512-324-3434</phone>
      <email>aimee.blake@ascension.org</email>
    </contact>
    <investigator>
      <last_name>Peter Monteleone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lucas Ferrer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vamsi Krishna, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sachin Mehta, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiothoracic and Vascular Surgeons</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dana Finley</last_name>
      <phone>512-459-3300</phone>
      <email>danaf@ctvstexas.com</email>
    </contact>
    <investigator>
      <last_name>Mazin Foteh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Nation, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeffery Apple, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ryan Turley, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joe K. Wells, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor St Lukes Medical Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Iles Torres</last_name>
      <phone>713-798-3023</phone>
      <email>Ilse.TorresRuiz@bcm.edu</email>
    </contact>
    <investigator>
      <last_name>Miguel Montero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joseph Mills, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jayer Chung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zachery Palister, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Dallas Research Associates</name>
      <address>
        <city>McKinney</city>
        <state>Texas</state>
        <zip>75609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Irfan Ullah</last_name>
      <phone>972-562-2345</phone>
      <email>irfan@ndresearch.com</email>
    </contact>
    <investigator>
      <last_name>Muhammad Khan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ambreen Ashfaque, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hurricane Cardiology Research</name>
      <address>
        <city>New Braunfels</city>
        <state>Texas</state>
        <zip>78130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen L Hlozek, PhD</last_name>
      <phone>857-334-0851</phone>
      <email>kristen@hurricanecardiology.com</email>
    </contact>
    <investigator>
      <last_name>Jason A Yoho, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AZH Wound &amp; Vascular Center</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Becky Kastern</last_name>
      <phone>262-577-0260</phone>
      <email>bkastern@azhcenters.com</email>
    </contact>
    <investigator>
      <last_name>Awais Siddique, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 13, 2020</study_first_submitted>
  <study_first_submitted_qc>November 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PAD</keyword>
  <keyword>PVD</keyword>
  <keyword>SFA stent</keyword>
  <keyword>stent</keyword>
  <keyword>Helical stent</keyword>
  <keyword>Vascular stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

